Ichiro Yabe Selected Research

Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)

8/2019	The Responsiveness of Triaxial Accelerometer Measurement of Gait Ataxia Is Higher than That of the Scale for the Assessment and Rating of Ataxia in the Early Stages of Spinocerebellar Degeneration.
11/2015	Quantitative evaluation of gait ataxia by accelerometers.
1/2005	Treatment of cerebellar ataxia with 5-HT1A agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ichiro Yabe Research Topics

Disease

15	Parkinson Disease (Parkinson's Disease) 09/2021 - 01/2010
10	Cerebellar Ataxia (Dysmetria) 08/2019 - 04/2003
7	Multiple Sclerosis 04/2010 - 06/2002
6	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2022 - 08/2002
5	Disease Progression 09/2021 - 12/2002
5	Parkinsonian Disorders (Parkinsonism) 01/2021 - 07/2011
5	Ataxia (Dyssynergia) 12/2017 - 04/2002
5	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 08/2017 - 04/2002
4	Multiple System Atrophy 01/2019 - 04/2003
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2017 - 08/2002
4	Pain (Aches) 06/2013 - 04/2002
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2022 - 01/2009
3	Guillain-Barre Syndrome 12/2021 - 11/2016
3	Neoplasms (Cancer) 04/2021 - 05/2008
3	Weight Loss (Weight Reduction) 01/2021 - 01/2012
3	Spinal Cord Diseases 08/2020 - 02/2011
3	Paraplegia (Spastic Paraplegia) 08/2020 - 01/2006
3	Overactive Urinary Bladder (Overactive Bladder) 01/2020 - 01/2018
3	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 08/2019 - 01/2005
3	Mitochondrial Diseases (Mitochondrial Disease) 07/2017 - 08/2002
3	Neuromyelitis Optica (Devic's Disease) 01/2017 - 05/2012
3	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2014 - 07/2011
3	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2012 - 01/2007
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2005 - 04/2002
3	Anorexia 01/2005 - 04/2002
2	Encephalitis (Encephalitis, Rasmussen) 10/2022 - 03/2005
2	Amyloidosis 06/2022 - 12/2017
2	Muscle Weakness 12/2021 - 12/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 10/2021 - 01/2015
2	Seizures (Absence Seizure) 09/2021 - 08/2019
2	Infections 10/2020 - 12/2014
2	Amyloid Neuropathies (Amyloid Neuropathy) 10/2020 - 12/2017
2	Lower Urinary Tract Symptoms 05/2018 - 10/2016
2	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 02/2018 - 08/2007
2	Fever (Fevers) 10/2016 - 01/2012
2	POEMS Syndrome (Syndrome, POEMS) 10/2016 - 01/2015
2	Paraproteinemias (Monoclonal Gammopathy) 10/2016 - 01/2015
2	Dementia (Dementias) 04/2015 - 02/2008
2	Atrophy 09/2012 - 01/2005
2	Brain Diseases (Brain Disorder) 05/2012 - 04/2010
2	Demyelinating Diseases (Demyelinating Disease) 05/2012 - 12/2009
2	Bacterial Meningitis 01/2012 - 05/2009
2	Vasculitis (Vasculitides) 01/2012 - 01/2008
2	Lymphoma (Lymphomas) 01/2012 - 04/2010
2	Sarcoidosis (Schaumann Disease) 12/2011 - 02/2011
2	Autoimmune Diseases (Autoimmune Disease) 04/2010 - 10/2005
2	Polyneuropathies (Polyneuropathy) 03/2009 - 01/2009
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 12/2003 - 04/2003
1	Spastic Paraparesis 10/2022
1	Moyamoya Disease (Moya-Moya Disease) 08/2022
1	Complement Component 6 Deficiency 08/2022
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 06/2022
1	Inflammation (Inflammations) 04/2022
1	Gastroesophageal Reflux (GERD) 04/2022

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 08/2022 - 08/2002
10	AntibodiesIBA 04/2022 - 05/2008
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2009
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2005
4	Lactic Acid (Lactate)FDA LinkGeneric 07/2017 - 05/2009
3	Immunoglobulin G (IgG)IBA 10/2022 - 04/2010
3	Prealbumin (Transthyretin)IBA 06/2022 - 12/2017
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 01/2018
3	istradefyllineIBA 05/2018 - 10/2016
3	SteroidsIBA 01/2012 - 01/2008
3	tandospironeIBA 01/2005 - 04/2002
2	Intravenous Immunoglobulins (IVIG)FDA Link 12/2021 - 08/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 09/2021 - 08/2019
2	Estrogen ReceptorsIBA 01/2021 - 07/2002
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2021 - 01/2018
2	Codon (Codons)IBA 12/2020 - 06/2002
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 12/2003
2	IodineIBA 01/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 10/2015
2	AmifampridineIBA 02/2018 - 08/2007
2	eculizumab FDA Link 01/2018 - 11/2016
2	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 12/2014
2	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 04/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 01/2015
2	Thalidomide (Thalomid)FDA Link 10/2016 - 01/2015
2	Mitochondrial DNA (mtDNA)IBA 01/2014 - 09/2013
2	Levodopa (L Dopa)FDA LinkGeneric 01/2014 - 01/2010
2	neuromelaninIBA 09/2013 - 06/2013
2	Dopamine (Intropin)FDA LinkGeneric 06/2013 - 01/2010
2	Antitubercular AgentsIBA 01/2012 - 01/2007
2	SpastinIBA 02/2008 - 01/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2005 - 08/2002
2	Citric Acid (Citrate)FDA LinkGeneric 01/2005 - 01/2004
2	5-HT1A Serotonin ReceptorIBA 01/2005 - 01/2004
2	Serotonin 5-HT1 Receptor AgonistsIBA 01/2005 - 01/2004
2	HLA-DRB1 Chains (HLA DRB1)IBA 08/2003 - 07/2002
2	Free RadicalsIBA 02/2003 - 08/2002
2	Glutathione (Reduced Glutathione)IBA 02/2003 - 08/2002
1	Complement C6 (Complement 6)IBA 08/2022

Therapy/Procedure

13	Therapeutics 07/2021 - 01/2004
2	Deep Brain Stimulation 09/2021 - 01/2021
2	Immunotherapy 09/2021 - 08/2020
2	Activities of Daily Living (ADL) 02/2018 - 07/2014
2	Transplantation 12/2017 - 01/2015
2	Radiotherapy 03/2011 - 04/2010
1	Combined Modality Therapy 10/2022